Menu
Recruiting NCT06729762

Ultrasound-guided Thermal Ablation for Benign Thyroid Nodules

Observational Thyroid Nodule (Benign)

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: ultrasound-guided thermal ablation.
Who it may be relevant to
Registry conditions: Thyroid Nodule (Benign). Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Ultrasound-guided Thermal Ablation for the Treatment of Benign Thyroid Nodules: A Multicenter Study

Overview

To evaluate long-term outcomes of ultrasound-guided thermal ablation for benign thyroid nodules

Detailed description

To evaluate and predict long-term clinical outcomes of ultrasound-guided thermal ablation for benign thyroid nodules by a multicenter study

Interventions

  • Procedure ultrasound-guided thermal ablation
    radiofrequency ablation, microwave ablation, laser ablation

Primary outcome measures

  • volume reduction rate [Time frame: through study completion, an average of 6 months]
Secondary outcome measures (6)
  • rate of complications [Time frame: 1 week]
  • cosmetic score [Time frame: through study completion, an average of 6 months]
  • symptom score [Time frame: through study completion, an average of 6 months]
  • rate of nodule regrowth [Time frame: through study completion, an average of 6 months]
  • rate of change of thyroid function [Time frame: through study completion, an average of 6 months]
  • rate of disappearance [Time frame: through study completion, an average of 6 months]

Eligibility criteria

Inclusion criteria

  • confirmation of benign nodule status on two separate fine- needle aspiration or core-needle biopsy
  • no suspicious malignant features on ultrasound examination
  • report of cosmetic and/ or symptomatic problems or concern of nodules growing rapidly or malignant transformation
  • refusal or ineligibility for surgery
  • follow-up time ≥12 months

Exclusion criteria

  • follicular neoplasm or malignancy findings on biopsy
  • nodules with benign result on biopsy had suspicious of malignancy in US
  • patients with contra-lateral vocal cord paralysis
  • previous radiation to the head and neck
  • follow- up time less than 12 months

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

China · 1 center
  • Chinese PLA General Hospital — Beijing

Identifiers

NCT: NCT06729762 · 2024-654

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗